Cleerly ISCHEMIA vs Viz HCM

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

Cleerly ISCHEMIA

by Cleerly

Viz HCM

by Viz.ai

AI Verdict

Tool A, Cleerly ISCHEMIA, is designed for non-invasive detection and characterization of coronary artery ischemia using CCTA scans, aiding in personalized diagnosis and treatment planning for heart disease. In contrast, Tool B, Viz HCM, focuses on real-time detection of Hypertrophic Cardiomyopathy (HCM) through ECG analysis and coordinates cardiac care for this specific condition. While both are FDA-cleared cardiology AI tools, they address distinct cardiac conditions and utilize different diagnostic inputs, making them adjacent rather than direct competitors.

Choose Cleerly ISCHEMIA if…

Choose Cleerly ISCHEMIA if your primary goal is a comprehensive, non-invasive assessment of coronary artery disease, including the likelihood of ischemia and detailed plaque characterization. This tool is ideal for physicians seeking to leverage CCTA scans for personalized diagnosis and treatment planning based on vessel-level ischemia and anatomical insights.

View Cleerly ISCHEMIA →

Choose Viz HCM if…

Choose Viz HCM if your priority is real-time detection and rapid care coordination for suspected Hypertrophic Cardiomyopathy (HCM) directly from ECG analysis. This tool is best suited for health systems aiming to significantly reduce HCM diagnosis time through automated alerts and streamlined patient pathways to appropriate specialists.

View Viz HCM →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	Cleerly ISCHEMIA	Viz HCM
Deployment	Web-based solution	Unknown
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	Cleerly ISCHEMIA	Viz HCM
Name	Cleerly ISCHEMIA	Viz HCM
Company	Cleerly	Viz.ai
Primary Function	AI tool that analyzes CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level, aiding physicians in personalized diagnosis and treatment planning for heart disease.	AI tool that uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and coordinate cardiac care, significantly reducing diagnosis time.
Key Input Data	CCTA scans	Real-time ECG analysis
Target Condition/Disease	Coronary artery ischemia, heart disease	Hypertrophic Cardiomyopathy (HCM)

Videos

Demos, reviews, and walkthroughs featuring Cleerly ISCHEMIA and Viz HCM.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions do these AI tools help diagnose?

Cleerly ISCHEMIA is designed to analyze CCTA scans to non-invasively determine the likelihood of coronary artery ischemia at a vessel level. Viz HCM uses real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy (HCM) and aid in care coordination.

What type of patient data do these AI tools analyze?

Cleerly ISCHEMIA analyzes data from CCTA (Coronary CT Angiography) scans to provide its insights, including coronary plaque characterization and stenosis severity assessment. Viz HCM analyzes standard 12-lead electrocardiograms (ECGs) to detect patterns consistent with hypertrophic cardiomyopathy.

How do these tools integrate into existing clinical workflows and IT systems?

Cleerly ISCHEMIA is a web-based platform that transfers data via Cleerly Proxy, which can be a VPN or virtual appliance. Viz HCM is a cloud-based platform designed for seamless integration with hospital IT systems, including EHR and PACS.

Which medical specialties are these tools primarily designed for?

Cleerly ISCHEMIA is primarily intended for use by Cardiology and Radiology specialists. Viz HCM is designed for Cardiology, Emergency Medicine, and Hospital Medicine, aiming to streamline cardiac care coordination.

What are the key analytical capabilities and outputs of each tool?

Cleerly ISCHEMIA provides AI-enabled CCTA analysis, non-invasive fractional flow reserve (FFR) estimation, vessel-level ischemia likelihood determination, coronary plaque characterization, and stenosis severity assessment, presented in comprehensive interactive web-based reports. Viz HCM offers AI-powered ECG analysis for HCM detection, real-time mobile-based alerts to multidisciplinary care teams, and automated direction of patients to appropriate care specialists.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Cleerly ISCHEMIA or Viz HCM

Backers

Who funded each tool's parent company.

Cleerly ISCHEMIA

Viz HCM

Scale Venture Partners